+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Opisthorchiasis Treatment Market, By Type (Medications {Antibiotics, Anthelmintics, Others} v/s Surgery), By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others), By Symptom, By End User, By Region, Competition Forecast and Opportunities, 2017-2027

  • PDF Icon

    Report

  • 110 Pages
  • April 2022
  • Region: Global
  • TechSci Research
  • ID: 5575305
Free Webex Call
10% Free customization

The market growth can be attributed to the rising incidences of infectious diseases caused by liver fluke and cat fluke among the global population

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global opisthorchiasis treatment market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising incidences of infectious diseases caused by liver fluke and cat fluke among the global population. High demand for seafood due to their taste and nutritional value but lack of awareness about the parasitic infection caused by Opisthorchis Viverrini found in marine animals is boosting the growth of the global opisthorchiasis treatment market. Growing research and development activities for the early diagnosis and effective treatment options for diseases with advanced pharmaceutical products and surgical therapies. Prolonged infection exposure and the growing prevalence of chronic conditions in Asian countries like Thailand, Vietnam, Korea, and China are expected to fuel the growth of the global opisthorchiasis treatment market. Limited knowledge about the rules for disinfection of the local population and an increase in the number of amateur fishermen and poachers are contributing to the growing incidences of opisthorchiasis, which is propelling the growth of the global opisthorchiasis treatment market. Increasing awareness about the environmental depletion due to contamination of water sources in ocean and water bodies by untreated waste dump are further aiding to the rising infection in marine life, contributing to the growing liver infections among the global population. As people across the globe are increasingly becoming aware of the diseases and their available treatments, the demand for healthcare services and treatments is booming at an exponential rate. Moreover, the growing number of healthcare facilities, the emergence of new technologies, and rising innovation are expected to fuel the growth of the global opisthorchiasis treatment market during the forecast period.

The global opisthorchiasis treatment market is segmented on the basis on type, diagnostic procedure, symptom, end user, regional distribution, and competitive Landscape. Based on diagnostic procedure, the market is divided into Cholangiography, MRI, Ultrasonography, CT scan, and others. The Cholangiography segment is expected to hold the largest share in the global opisthorchiasis treatment market due to the standardization of stool examination. Based on end-user, the market is fragmented into hospitals & clinics, ambulatory care centres, and others. The hospitals & clinics segment is anticipated to dominate the global opisthorchiasis treatment market as they provide better medical equipment, products, and services to the patients.

Major players operating in the global opisthorchiasis treatment market include Cipla Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Merck KGaA, Boehringer Ingelheim International GmbH, Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., AbbVie Inc., Mankind Pharma Limited, among others.

Years Considered for This Report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022E
  • Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global opisthorchiasis treatment market from 2017 to 2021
  • To estimate and forecast the market size of global opisthorchiasis treatment market from 2022E to 2027F and growth rate until 2027F
  • To classify and forecast global opisthorchiasis treatment market based on type, diagnostic procedure, symtom, end user, region, and competitive Landscape
  • To identify dominant region or segment in the global opisthorchiasis treatment market
  • To identify drivers and challenges for global opisthorchiasis treatment market
  • To examine competitive developments such as expansions, new services, mergers & acquisitions, etc, in global opisthorchiasis treatment market
  • To identify and analyze the profile of leading players operating in global opisthorchiasis treatment market
  • To identify key sustainable strategies adopted by market players in global opisthorchiasis treatment market

Report Scope:


In this report, global opisthorchiasis treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Opisthorchiasis Treatment Market, By Type:

  • Medications
  • Antibiotics
  • Anthelmintics
  • Others
  • Surgery

Opisthorchiasis Treatment Market, By Diagnostic Procedure:

  • Cholangiography
  • MRI
  • Ultrasonography
  • CT scan
  • Others

Opisthorchiasis Treatment Market, By Symptom:

  • Jaundice
  • Diarrhea
  • Fever
  • Splenomegaly
  • Weight loss
  • Tachycardia
  • Others

Opisthorchiasis Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Opisthorchiasis Treatment Market, By Region:


North America

  • United States
  • Mexico
  • Canada
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies, which could not be identified due to the limitations of secondary research. The publisher analyzed the companies and presence of all major players across the globe.

The publisher calculated the market size of the global opisthorchiasis treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these treatment types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

  • Opisthorchiasis treatment service provider companies/partners
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global opisthorchiasis treatment market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in global opisthorchiasis treatment market

Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:
  • Company Information
  • Detailed analysis and profiling of additional market players (up to five)


This product will be delivered within 1-3 business days.

Table of Contents

1. Service Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Global Opisthorchiasis Treatment Market
5. Voice of Customer
5.1. Prevalence, By Geography
5.2. Prevalence, By Gender
5.3. Commonly Observed Symptoms
5.4. Preferred Choice of Treatment
6. Global Opisthorchiasis Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Medications v/s Surgery)
6.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
6.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
6.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Opisthorchiasis Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Medications v/s Surgery)
7.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
7.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
7.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
7.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Opisthorchiasis Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Diagnostic Procedure
7.3.1.2.3. By Symptom
7.3.1.2.4. By End User
7.3.2. Mexico Opisthorchiasis Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Diagnostic Procedure
7.3.2.2.3. By Symptom
7.3.2.2.4. By End User
7.3.3. Canada Opisthorchiasis Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Diagnostic Procedure
7.3.3.2.3. By Symptom
7.3.3.2.4. By End User
8. Europe Opisthorchiasis Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Medications v/s Surgery)
8.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
8.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
8.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
8.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Opisthorchiasis Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Diagnostic Procedure
8.3.1.2.3. By Symptom
8.3.1.2.4. By End User
8.3.2. Germany Opisthorchiasis Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Diagnostic Procedure
8.3.2.2.3. By Symptom
8.3.2.2.4. By End User
8.3.3. United Kingdom Opisthorchiasis Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Diagnostic Procedure
8.3.3.2.3. By Symptom
8.3.3.2.4. By End User
8.3.4. Italy Opisthorchiasis Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Diagnostic Procedure
8.3.4.2.3. By Symptom
8.3.4.2.4. By End User
8.3.5. Spain Opisthorchiasis Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Diagnostic Procedure
8.3.5.2.3. By Symptom
8.3.5.2.4. By End User
9. Asia-Pacific Opisthorchiasis Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Medications v/s Surgery)
9.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
9.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
9.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
9.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Opisthorchiasis Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Diagnostic Procedure
9.3.1.2.3. By Symptom
9.3.1.2.4. By End User
9.3.2. India Opisthorchiasis Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Diagnostic Procedure
9.3.2.2.3. By Symptom
9.3.2.2.4. By End User
9.3.3. South Korea Opisthorchiasis Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Diagnostic Procedure
9.3.3.2.3. By Symptom
9.3.3.2.4. By End User
9.3.4. Japan Opisthorchiasis Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Diagnostic Procedure
9.3.4.2.3. By Symptom
9.3.4.2.4. By End User
9.3.5. Australia Opisthorchiasis Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Diagnostic Procedure
9.3.5.2.3. By Symptom
9.3.5.2.4. By End User
10. South America Opisthorchiasis Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Medications v/s Surgery)
10.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
10.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
10.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
10.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Opisthorchiasis Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Diagnostic Procedure
10.3.1.2.3. By Symptom
10.3.1.2.4. By End User
10.3.2. Argentina Opisthorchiasis Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Diagnostic Procedure
10.3.2.2.3. By Symptom
10.3.2.2.4. By End User
10.3.3. Colombia Opisthorchiasis Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Diagnostic Procedure
10.3.3.2.3. By Symptom
10.3.3.2.4. By End User
11. Middle East and Africa Opisthorchiasis Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type (Medications v/s Surgery)
11.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
11.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
11.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
11.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Opisthorchiasis Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Diagnostic Procedure
11.3.1.2.3. By Symptom
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Opisthorchiasis Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Diagnostic Procedure
11.3.2.2.3. By Symptom
11.3.2.2.4. By End User
11.3.3. UAE Opisthorchiasis Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Diagnostic Procedure
11.3.3.2.3. By Symptom
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Cipla Inc.
14.2. Johnson & Johnson
14.3. Sun Pharmaceutical Industries Ltd.
14.4. Merck KGaA
14.5. Boehringer Ingelheim International GmbH
14.6. Pfizer Inc.
14.7. GlaxoSmithKline plc
14.8. F. Hoffmann-La Roche Ltd
14.9. AbbVie Inc
14.10. Mankind Pharma Limited
15. Strategic Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cipla Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd.
  • Merck KGaA
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc
  • Mankind Pharma Limited